SPYRE THERAPEUTICS, INC. Property, Plant and Equipment
SPYRE THERAPEUTICS, INC. (SYRE) had Property, Plant and Equipment of $0 as of 2023-12-31, per its 10-K/A filed 2024-11-18.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2024-11-18
- 2023-12-31: Property, Plant and Equipment, Net $0.00.
- 2023-09-30: Property, Plant and Equipment, Net $0.00.
- 2023-06-30: Property, Plant and Equipment, Net $0.00.
- 2023-03-31: Property, Plant and Equipment, Net $3.42M.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2023-12-31 | $0.00 10-K/A · filed 2024-11-18 |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-11 |
| 2023-03-31 | $3.42M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.22M 10-K/A · filed 2024-11-18 |
| 2022-09-30 | $3.56M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.89M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.23M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.55M 10-K · filed 2023-03-02 |
| 2021-09-30 | $4.92M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $5.21M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $5.52M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $5.64M 10-K · filed 2022-03-08 |
| 2020-09-30 | $5.22M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $4.90M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $4.24M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.38M 10-K · filed 2021-03-18 |
| 2019-09-30 | $980.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $921.00K 10-Q · filed 2019-08-06 |
| 2019-03-31 | $952.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | $1.02M 10-K · filed 2020-02-24 |
| 2018-09-30 | $846.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $776.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $810.00K 10-Q · filed 2018-05-08 |
| 2017-12-31 | $854.00K 10-K · filed 2019-03-07 |
| 2017-09-30 | $844.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | $802.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $822.00K 10-Q · filed 2017-05-09 |
| 2016-12-31 | $599.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $342.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $377.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $321.00K 10-Q · filed 2016-05-19 |
| 2015-12-31 | $348.00K 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |